FBR Capital upped its price targets for Schlumberger (SLB), Halliburton (HAL) and Baker Hughes (BHI) and to reflect its belief that there will a "tighter balance" and "healthier" pricing over the next up-cycle. FBR upped its target for Schlumberger to $110 from $102, for Halliburton to $50 from $44 and for Baker Hughes to $75 from $68. It recommends buying shares of Schlumberger and Baker Hughes following the recent underperformance.

Unusual total active option classes on open include: ImmunityBio (IBRX), Halliburton (HAL), Redfin (RDFN), Nokia (NOK), Matterport (MTTR), General Motors (GM), UPS (UPS), Philip Morris (PM), PepsiCo (PEP), and General Electric (GE).

Reports Q1 revenue $5.8B, consensus $5.67B. "Halliburton delivered solid first quarter results that again demonstrated the power of our strategy and the strength of our execution. Activity in North America recovered from fourth-quarter lows, and our international business delivered its 11th consecutive quarter of year-on-year growth," commented Jeff Miller, Chairman, President and CEO. "Our customers' multi-year activity plans across markets and asset types confirms my confidence in the strength and duration of this upcycle. Halliburton demonstrated its commitment to shareholder returns in the first quarter and repurchased $250 million of common stock - a solid start to the year and a good benchmark for our expectations going forward," concluded Miller.